Category: Accuray Inc.
Accuray slashes Q2 losses and ups its earnings expectations for the year, prompting a 13% boost from Wall Street.
California radiation oncology systems maker Accuray (NSDQ:ARAY) scored major Wall Street points with its 2nd quarter financial report, with shares soaring on news of lowered losses and increased guidance for the year.
Accuray shares are up today after the medical device company reports reduced losses and increased profit margins.
Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.
Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.
Accuray CFO Derek Bertocci steps down to spend some time with his family, former Conceptus CFO Gregory Lichtwardt takes his place.
Radiosurgery systems maker Accuray gains more than 10% after releasing its 4th quarter earnings report.
Wall Street piled favor on California radiosurgery systems maker Accuray (NSDQ:ARAY) after the company narrowed losses in its 4th quarter, even as sales dropped by more than 15%.
Radiosurgical devices maker Accuray posted a 30% cut in sales during its 3rd quarter, but CEO Levine says he's "encouraged" by an uptick in order volume.
Medical device maker Accuray (NSDQ:ARAY) managed to get some Wall Street love after posting a rather harsh 3rd quarter earnings report this week, with investors likely reacting to news of promising order volume growth quarter-over-quarter.
Medical device company Accuray explains its action to remove 2 potentially defective components of its flagship CyberKnife radiosurgery platform.
Radiosurgery devices maker Accuray (NSDQ:ARAY) released an official statement on the recall of a pair of components of its CyberKnife radiosurgery systems, warning that the devices were not manufactured to standard.